Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. [electronic resource]
Producer: 19940314Description: 749-55 p. digitalISSN:- 0008-5472
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blotting, Western
- Cell Cycle -- physiology
- Cyclophosphamide -- administration & dosage
- DNA Damage
- DNA Topoisomerases, Type I -- analysis
- DNA Topoisomerases, Type II -- analysis
- DNA, Neoplasm -- analysis
- Female
- Flow Cytometry
- Humans
- Isoenzymes -- antagonists & inhibitors
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Teniposide -- pharmacology
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.